Safety of the Antibody Screening Test as the Sole Method of Pretransfusion Testing

Vox Sanguinis ◽  
1992 ◽  
Vol 63 (2) ◽  
pp. 141-141 ◽  
Author(s):  
Javier Rubia ◽  
A. Sempere ◽  
F. Arriaga ◽  
F. López ◽  
M. L. Marty
2019 ◽  
Vol 30 (3) ◽  
pp. 241-245
Author(s):  
Han-Sol Kim ◽  
Chae-Ku Jo ◽  
Sin-Young Kim ◽  
Kyeong-Hee Kim ◽  
Myo-Jing Kim

2003 ◽  
Vol 18 (5) ◽  
pp. 669 ◽  
Author(s):  
Tae Sung Park ◽  
Seung Hwan Oh ◽  
Jae Cheol Choi ◽  
Dae Dong Lee ◽  
Hyung Hoi Kim ◽  
...  

Vox Sanguinis ◽  
1994 ◽  
Vol 66 (3) ◽  
pp. 210-215
Author(s):  
S.T. Lillevang ◽  
J. Georgsen ◽  
T. Kristensen

2015 ◽  
Vol 26 (1) ◽  
pp. 47-53 ◽  
Author(s):  
Ju-Mee Lee ◽  
Nam-Hee Kim ◽  
Kyung-Hwa Shin ◽  
Hyun-Ji Lee ◽  
Chulhun L. Chang ◽  
...  

1985 ◽  
Vol 38 (1) ◽  
pp. 111-113 ◽  
Author(s):  
S M Henry ◽  
A M Ramirez ◽  
D G Woodfield

2004 ◽  
Vol 118 (5) ◽  
pp. 362-365 ◽  
Author(s):  
Caroline Ryan ◽  
Chirajit Dutta ◽  
Ricard Simo

Two hundred and four cases of in-patient admission with isolated, unilateral peritonsillar abscess over the three-year period 1999–2001 were reviewed retrospectively. One hundred and fifty-one patients had been screened for infectious mononucleosis (IM) using the heterophile antibody screening test. Of these 142 (94 per cent) tested negative and nine (six per cent) positive. There were no IM-typical clinical or haematological signs in any of the IM positive patients to facilitate the prediction of the diagnosis. Due to the comparatively high prevalence of positives, the low cost of screening, the lack of predictive signs and the diversity of potential complications of IM, routine screening in all patients presenting with peritonsillar abscess is recommended.


Sign in / Sign up

Export Citation Format

Share Document